Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Gross Margin: 2020-2025

Historic Gross Margin for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to 70.74%.

  • Biofrontera's Gross Margin rose 2485.00% to 70.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.41%, marking a year-over-year decrease of 171.00%. This contributed to the annual value of 50.14% for FY2024, which is 134.00% up from last year.
  • Biofrontera's Gross Margin amounted to 70.74% in Q3 2025, which was down 0.01% from 70.74% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Gross Margin peaked at 112.80% during Q4 2023, and registered a low of -77.84% during Q2 2023.
  • Its 3-year average for Gross Margin is 47.72%, with a median of 47.98% in 2024.
  • Within the past 5 years, the most significant YoY rise in Biofrontera's Gross Margin was 18,507bps (2023), while the steepest drop was 17,443bps (2023).
  • Quarterly analysis of 5 years shows Biofrontera's Gross Margin stood at 98.03% in 2021, then crashed by 17,030bps to -72.27% in 2022, then soared by 18,507bps to 112.80% in 2023, then crashed by 5,477bps to 58.03% in 2024, then surged by 2,485bps to 70.74% in 2025.
  • Its last three reported values are 70.74% in Q3 2025, 70.74% for Q2 2025, and 61.95% during Q1 2025.